Glycogen synthase kinase-3β inhibitor reduces LPS-induced acute lung injury in mice

Molecular Medicine Reports

Volumn 16, Issue 5, 2017, Pages 6715-6721

  Ding, Qi ^a,b   Liu, Gaoqin ^a   Zeng, Yuanyuan ^a   Zhu, Jianjie ^a   Liu, Zeyi ^a   Jiang, Junhong ^a   Huang, Jianan ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Inflammation; Neutrophil; Respiratory distress syndrome; Wnt signaling

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ALBUMIN; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN M; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; CYTOKINE; PROTEIN KINASE INHIBITOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG ALVEOLUS CELL TYPE 2; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WNT SIGNALING; ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; LUNG; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ACUTE LUNG INJURY; ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3 BETA; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PROTEIN KINASE INHIBITORS;

EID: 85030127197     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.7469     Document Type: Article

References (37)

1. Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342:1334-1349, 2000.
2. Goss CH, Brower RG, Hudson LD and Rubenfeld GD; ARDS Network: Incidence of acute lung injury in the United States. Crit Care Med 31:1607-1611, 2003.
3. Mendez JL and Hubmayr RD: New insights into the pathology of acute respiratory failure. Curr Opin Crit Care 11:29-36, 2005.
4. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 353:1685-1693, 2005.
5. Quílez ME, López-Aguilar J and Blanch L: Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation. Curr Opin Crit Care 18:23-28, 2012.
6. Middelveld RJ and Alving K: Synergistic septicemic action of the gram-positive bacterial cell wall components peptidoglycan and lipoteichonic acid in the pig in vivo. Shock 13:297-306, 2000.
7. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S and Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 29:628-634, 2001.
8. Tanaka S, Nishiumi S, Nishida M, Mizushina Y, Kobayashi K, Masuda A, Fujita T, Morita Y, Mizuno S, Kutsumi H, et al: Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activationce. Clin Exp Immunol 160:283-292, 2010.
9. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, et al: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055-2064, 2012.
10. Huber-Lang MS, Younkin EM, Sarma JV, McGuire SR, Lu KT, Guo RF, Padgaonkar VA, Curnutte JT, Erickson R and Ward PA: Complement-induced impairment of innate immunity during sepsis. J Immunol 169:3223-3231, 2002.
11. Riedemann NC, Guo RF, Neff TA, Laudes IJ, Keller KA, Sarma VJ, Markiewski MM, Mastellos D, Strey CW, Pierson CL, et al: Increased C5a receptor expression in sepsis. J Clin Invest 110:101-108, 2002.
12. Lehmann LE, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, Hoeft A and Stüber F: Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 27:1412-1415, 2001.
13. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP and Tracey KJ: Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci. USA 99:12351-12356, 2002.
14. Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H and Grigoryev SA, et al: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184:205-213, 2009.
15. Bouldin CM, Manning AJ, Peng YH, Farr GH III, Hung KL, Dong A and Kimelman D: Wnt signaling and tbx16 form a bistable switch to commit bipotential progenitors to mesoderm. Development 142:2499-2507, 2015.
16. Etheridge SL, Spencer GJ, Heath DJ and Genever PG: Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849-860, 2004.
17. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100:8407-8411, 2003.
18. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, Suzuki T and Sasaki H: Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 172:1266-1272, 2004.
19. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC and Fine A: Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128:5181-5188, 2001.
20. Gupta N, Su X, Popov B, Lee JW, Serikov V and Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:1855-1863, 2007.
21. Geburek F, Mundle K, Conrad S, Hellige M, Walliser U, van Schie HT, van Weeren R, Skutella T and Stadler PM: Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions - a pilot study. Stem Cell Res Ther 7:21, 2016.
22. Takaoka Y, Goto S, Nakano T, Tseng HP, Yang SM, Kawamoto S, Ono K and Chen CL: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice. Sci Rep 4:5204, 2014.
23. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC and Stewart DJ: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4:e269, 2007.
24. Fang WF, Cho JH, He Q, Lin MC, Wu CC, Voelkel NF and Douglas IS: Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury. Am J Physiol Lung Cell Mol Physiol 293:L336-L344, 2007.
25. Dong L, He HL, Lu XM, Yang Y and Qiu HB: Modulation of FLT3 signaling targets conventional dendritic cells to attenuate acute lung injury. APMIS 120:808-818, 2012.
26. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR and Liles WC: Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation. Am J Pathol 158:153-161, 2001.
27. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810, 2004.
28. Gordon MD and Nusse R: Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429-22433, 2006.
29. Troussard AA, Tan C, Yoganathan TN and Dedhar S: Cellextracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol Cell Biol 19:7420-7427, 1999.
30. Jean D, Harbison M, McConkey DJ, Ronai Z and Bar-Eli M: CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 273:24884-24890, 1998.
31. Walton M, Woodgate AM, Muravlev A, Xu R, During MJ and Dragunow M: CREB phosphorylation promotes nerve cell survival. J Neurochem 73:1836-1842, 1999.
32. Kurosaki T: Checks and balances on developing B cells. Nat Immunol 4:13-15, 2003.
33. Masterson C, Jerkic M, Curley GF and Laffey JG: Mesenchymal stromal cell therapies: Potential and pitfalls for ARDS. Minerva Anestesiol 81:179-194, 2015.
34. Li J, Huang S, Wu Y, Gu C, Gao D, Feng C, Wu X and Fu X: Paracrine factors from mesenchymal stem cells: A proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome. Int Wound J 11:114-121, 2014.
35. Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, et al: In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl Med 4:1199-1213, 2015.
36. Grove JE, Lutzko C, Priller J, Henegariu O, Theise ND, Kohn DB and Krause DS: Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. Am J Respir Cell Mol Biol 27:645-651, 2002.
37. Liu AR, Liu L, Chen S, Yang Y, Zhao HJ, Liu L, Guo FM, Lu XM and Qiu HB: Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol 228:1270-1283, 2013.